Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD

11.47  +0.82 (+7.7%)

After market: 11.47 0 (0%)

Fundamental Rating

4

Taking everything into account, CLB scores 4 out of 10 in our fundamental rating. CLB was compared to 63 industry peers in the Energy Equipment & Services industry. CLB has only an average score on both its financial health and profitability. CLB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CLB was profitable.
CLB had a positive operating cash flow in the past year.
CLB had positive earnings in 4 of the past 5 years.
CLB had a positive operating cash flow in each of the past 5 years.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

The Return On Assets of CLB (4.74%) is comparable to the rest of the industry.
With a decent Return On Equity value of 11.06%, CLB is doing good in the industry, outperforming 65.08% of the companies in the same industry.
CLB has a Return On Invested Capital of 9.43%. This is in the better half of the industry: CLB outperforms 69.84% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 8.51%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.74%
ROE 11.06%
ROIC 9.43%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With a Profit Margin value of 5.41%, CLB perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
In the last couple of years the Profit Margin of CLB has declined.
Looking at the Operating Margin, with a value of 11.14%, CLB is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Operating Margin of CLB has declined.
CLB has a Gross Margin of 19.77%. This is in the lower half of the industry: CLB underperforms 71.43% of its industry peers.
In the last couple of years the Gross Margin of CLB has declined.
Industry RankSector Rank
OM 11.14%
PM (TTM) 5.41%
GM 19.77%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
CLB has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLB has been increased compared to 5 years ago.
Compared to 1 year ago, CLB has an improved debt to assets ratio.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CLB has an Altman-Z score of 2.69. This is not the best score and indicates that CLB is in the grey zone with still only limited risk for bankruptcy at the moment.
CLB has a Altman-Z score of 2.69. This is in the better half of the industry: CLB outperforms 74.60% of its industry peers.
The Debt to FCF ratio of CLB is 2.83, which is a good value as it means it would take CLB, 2.83 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.83, CLB is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CLB has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.49, CLB perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 2.83
Altman-Z 2.69
ROIC/WACC1.01
WACC9.3%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.21 indicates that CLB has no problem at all paying its short term obligations.
CLB has a better Current ratio (2.21) than 66.67% of its industry peers.
CLB has a Quick Ratio of 1.64. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
CLB's Quick ratio of 1.64 is fine compared to the rest of the industry. CLB outperforms 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.64
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

CLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.47%.
Measured over the past years, CLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.14% on average per year.
The Revenue has been growing slightly by 1.32% in the past year.
Measured over the past years, CLB shows a decrease in Revenue. The Revenue has been decreasing by -4.75% on average per year.
EPS 1Y (TTM)2.47%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-26.32%
Revenue 1Y (TTM)1.32%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-4.67%

3.2 Future

CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
The Revenue is expected to grow by 3.47% on average over the next years.
EPS Next Y-8.53%
EPS Next 2Y-1.72%
EPS Next 3Y9.05%
EPS Next 5Y12.78%
Revenue Next Year-2.42%
Revenue Next 2Y0.36%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.82, the valuation of CLB can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of CLB is on the same level as its industry peers.
CLB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.46, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.49, the valuation of CLB can be described as correct.
The rest of the industry has a similar Price/Forward Earnings ratio as CLB.
CLB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.30.
Industry RankSector Rank
PE 13.82
Fwd PE 13.49
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLB indicates a slightly more expensive valuation: CLB is more expensive than 76.19% of the companies listed in the same industry.
CLB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.23
EV/EBITDA 8.3
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.72%
EPS Next 3Y9.05%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.36%, CLB is not a good candidate for dividend investing.
The stock price of CLB dropped by -22.76% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CLB's Dividend Yield is comparable with the industry average which is at 3.82.
Compared to an average S&P500 Dividend Yield of 2.38, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

6.70% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP6.7%
EPS Next 2Y-1.72%
EPS Next 3Y9.05%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CORE LABORATORIES INC

NYSE:CLB (6/3/2025, 8:04:00 PM)

After market: 11.47 0 (0%)

11.47

+0.82 (+7.7%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners112.55%
Inst Owner Change0.91%
Ins Owners0.98%
Ins Owner Change7.23%
Market Cap537.71M
Analysts50
Price Target15.71 (36.97%)
Short Float %16.79%
Short Ratio14.69
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP6.7%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-05 2025-05-05 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.47%
Min EPS beat(2)-4.67%
Max EPS beat(2)-0.26%
EPS beat(4)2
Avg EPS beat(4)1.95%
Min EPS beat(4)-4.67%
Max EPS beat(4)7.15%
EPS beat(8)4
Avg EPS beat(8)3.65%
EPS beat(12)7
Avg EPS beat(12)4.64%
EPS beat(16)7
Avg EPS beat(16)1.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-1.71%
Revenue beat(12)2
Avg Revenue beat(12)-1.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.54%
PT rev (1m)-8.33%
PT rev (3m)-18.09%
EPS NQ rev (1m)2.19%
EPS NQ rev (3m)-10.51%
EPS NY rev (1m)-2.07%
EPS NY rev (3m)-12.21%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-2.01%
Revenue NY rev (1m)-4.15%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE 13.82
Fwd PE 13.49
P/S 1.04
P/FCF 12.23
P/OCF 9.35
P/B 2.12
P/tB 3.64
EV/EBITDA 8.3
EPS(TTM)0.83
EY7.24%
EPS(NY)0.85
Fwd EY7.41%
FCF(TTM)0.94
FCFY8.18%
OCF(TTM)1.23
OCFY10.7%
SpS11.05
BVpS5.41
TBVpS3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.74%
ROE 11.06%
ROCE 11.82%
ROIC 9.43%
ROICexc 9.87%
ROICexgc 12.77%
OM 11.14%
PM (TTM) 5.41%
GM 19.77%
FCFM 8.49%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexcg growth 3Y11.32%
ROICexcg growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 2.83
Debt/EBITDA 1.72
Cap/Depr 91.42%
Cap/Sales 2.62%
Interest Coverage 5.86
Cash Conversion 79.34%
Profit Quality 156.87%
Current Ratio 2.21
Quick Ratio 1.64
Altman-Z 2.69
F-Score6
WACC9.3%
ROIC/WACC1.01
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.47%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-26.32%
EPS Next Y-8.53%
EPS Next 2Y-1.72%
EPS Next 3Y9.05%
EPS Next 5Y12.78%
Revenue 1Y (TTM)1.32%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-4.67%
Revenue Next Year-2.42%
Revenue Next 2Y0.36%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-4.22%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year11.28%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y586.92%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y248.59%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%